4.7 Article

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 75, 期 4, 页码 674-680

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2014-206879

关键词

-

资金

  1. Rheumatology Research University Nijmegen foundation
  2. Merck/Schering-Plough
  3. Abbott
  4. BMS
  5. Pfizer/Wyeth
  6. Genentec
  7. Hoffman-La Roche
  8. Pfizer
  9. Roche
  10. UCB
  11. Medical Research Council [MR/K00414X/1] Funding Source: researchfish
  12. MRC [MR/K00414X/1] Funding Source: UKRI

向作者/读者索取更多资源

Objectives Predictive performance of cardiovascular disease (CVD) risk calculators appears suboptimal in rheumatoid arthritis (RA). A disease-specific CVD risk algorithm may improve CVD risk prediction in RA. The objectives of this study are to adapt the Systematic COronary Risk Evaluation (SCORE) algorithm with determinants of CVD risk in RA and to assess the accuracy of CVD risk prediction calculated with the adapted SCORE algorithm. Methods Data from the Nijmegen early RA inception cohort were used. The primary outcome was first CVD events. The SCORE algorithm was recalibrated by reweighing included traditional CVD risk factors and adapted by adding other potential predictors of CVD. Predictive performance of the recalibrated and adapted SCORE algorithms was assessed and the adapted SCORE was externally validated. Results Of the 1016 included patients with RA, 103 patients experienced a CVD event. Discriminatory ability was comparable across the original, recalibrated and adapted SCORE algorithms. The Hosmer-Lemeshow test results indicated that all three algorithms provided poor model fit (p < 0.05) for the Nijmegen and external validation cohort. The adapted SCORE algorithm mainly improves CVD risk estimation in non-event cases and does not show a clear advantage in reclassifying patients with RA who develop CVD (event cases) into more appropriate risk groups. Conclusions This study demonstrates for the first time that adaptations of the SCORE algorithm do not provide sufficient improvement in risk prediction of future CVD in RA to serve as an appropriate alternative to the original SCORE. Risk assessment using the original SCORE algorithm may underestimate CVD risk in patients with RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据